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1070-129 Elderly Acute Coronary Syndrome Patients Were 
Undertreated With Worse One-Year Outcome: Findings 
From a Contemporary Registry
Raymond T. Yan, Andrew T. Yan, Mary Tan, Chi-Ming Chow, David H. Fitchett, Frank L. 
Ervin, Heather Martin, James Y. Cha, Anatoly Langer, Shaun G. Goodman, Canadian 
Heart Research Centre, Toronto, ON, Canada, University of Toronto, Toronto, ON, 
Canada
Background: Age-related differences in patients with acute coronary syndrome (ACS)
were not well characterized in prior observational studies which often included only cer-
tain age-groups or subjects with myocardial infarction (MI).
Methods: The ACS Registry was a Canadian prospective observational study of 5312
patients with suspected ACS from 51 centres. Baseline demographic data, treatment and
outcome in hospital were recorded on case report forms. One-year outcome was deter-
mined by standardized telephone interview. We examined 4627 patients (87.1%) with
confirmed ACS in three age-groups (in years: <65; 65-74; >75) for differences in clinical
characteristics, treatment and outcome.
Results: Older patients were more often female, with previous angina, MI, or heart fail-
ure. (See Table) 
For trend: *P<0.001; **P=0.039
In multivariable analyses, increasing age was independently associated with reduced uti-
lization of catheterization, PCI and CABG. When further adjusted for treatment differ-
ences, every decade of age increment independently predicted higher risk of death (OR 
[odds ratio] 1.97; P<0.001) and the composite of death and non-fatal MI (OR 1.46; 
P<0.001) at 1-year.
Conclusions: Elderly ACS patients had substantially more complex co-morbidities and 
worse outcome yet they were less likely to be revascularized or receive evidence-based 
therapies. These findings emphasize the ongoing need to evaluate, and to improve 
adherence to, optimal therapeutic regimens for elderly patients. 
1070-130 Sex Difference in Age Dependence of Global and 
Regional Repolarisation Heterogeneity
Peter Smetana, Katerina Hnatkova, Gregory D. Sides, Alexei A. Dmitrienko, Scott A. 
Getzin, Dawn Rebhuhn, Marek Malik, St.George's Hospital Medical School, London, 
United Kingdom, Eli Lilly and Company, Indianapolis, IN
Background: Sex differences of repolarisation heterogeneity (RH) were suggested to
partly explain sex differences in arrhythmic risk. Age related differences in myocardial
structure and function were described repeatedly. However, their influence on RH is still
to be determined. We therefore investigated the influence of age on two ECG-descriptors
of RH. 
Methods: The study used an extensive clinical trial database of 15504 digital 12-lead
resting ECGs obtained in 9351 women and 6153 men of various age groups. From the
median beat of each ECG two descriptors of repolarisation heterogeneity were com-
puted. While a large cosine of the angle between QRS and T vector (TCRT) reflects a
homogeneous global distribution of APDs, high values of the non-dipolar component of
the T wave (TWR) reflect increased local heterogeneities. Individual results were
grouped for women and men. The age relation was analysed in a 10-y window moving in
1-y steps from 20 to 80 ys.
Results: While in men local heterogeneities increased more than in women (men vs
women 20-29yrs: 0.03± 0.04 vs 0.05± 0.06, p<0.005; 70-79yrs: 0.07± 0.05 vs 0.1± 0.1
p=0.227), it was the opposite in global heterogeneity. In men TCRT was only little influ-
enced by age whereas it markedly decreased in women (men vs women 20-29yrs: 0.32±
0.47 vs 0.62± 0.34, p<0.005; 70-79yrs: 0.54± 0.48 vs 0.34± 0.57, p=0.039).
Conclusions: Both global and regional RH is increased at higher age. Therefore age-
related changes of myocardial structure are likely to increase arrhythmic risk.
1070-131 Protective Effect of Diazoxide Is Maintained in Aged 
Heart
Arshad Jahangir, Ekhson Holmuhamedov, Andrew Oberlin, Nadeem Ashfaque, Andre 
Terzic, Mayo Clinic, Rochester, MN
Aging is associated with increased susceptibility of the heart to injury. Diazoxide (D), a
mitochondrial potassium channel opener, have been shown to protect cardiac mitochon-
dria and adult (Ad) heart against ischemia re-oxygenation injury. However the protective
action of diazoxide in aged myocardium, with attenuated ischemic preconditioning, has
not been studied. Mitochondria from senescent hearts (Sn) demonstrated significantly
reduced ability to accumulate and retain extramitochondrial Ca2+, introduced into sus-
pension as a sequential pulses of the known amount of Ca2+ (Figure A). Structural dam-
ages to aged mitochondria induced by Ca2+ overload as evaluated using electron
microscopy images, were significantly attenuated by diazoxide (Figure B). The protective
effect of diazoxide against metabolic stress was also observed in ouabain-stressed aged
cardiomyocytes as diazoxide-mediated suppression of production of free radicals, a criti-
cal mediator of cell injury (Figure C). The rate of production of free radicals in stressed
cardiomyocytes was monitored using confocal microscopy and fluorescent dye, 2,3-
dichlorofluorescein (DCF) diacetate loaded into the cells. Although, diazoxide signifi-
cantly attenuated the ouabain-mediated production of free radicals in adult and aged car-
diomyocytes, the attenuation of radical generation was greater in senescent than adult
cardiomyocytes. Diazoxide also protected the whole aged heart against ischemia and
reperfusion injury. Drop in developed left ventricular pressure following ischemic insult
(C) which was not preserved by endogenous mechanism of ischemic preconditioning
(PC) was significantly improved in the presence of diazoxide. Cardioprotective efficacy of
diazoxide translated also into maintained cellular ATP level. In conclusion, our study
demonstrate that cardioprotective effect of diazoxide could be demonstrated at the level
of isolated mitochondria, single cell and the whole heart, indicating its cardioprotective
potential in aging.
1070-132 Management and Outcome of Elderly Women and Men 
With Acute Coronary Syndromes: A Prospective 
Observational Community-Based Study in 2000 and 
2002
Mady Moriel, Solomon Behar, Dan Tzivoni, Valentina Boyko, Hanoch Hod, Shmuel 
Gottlieb, Neufeld Cardiac Research Institute, Tel HaShomer, Israel
Prior studies have suggested that women (W) with acute myocardial infarction are older,
treated less aggressively and experience worse outcome than men (M).
Purpose: To assess gender differences in treatment and outcome of elderly (age >70y)
patients (pts) with acute coronary syndromes (ACS).
Methods: Elderly ACS pts (511W, 820M) were hospitalized in all 26 CCUs in Israel, dur-
ing 2 prospective 2-months ACS National Surveys conducted in 2000 and 2002.
Results (see Table): After covariate adjustment OR (95% CI) for 7-day mortality, was
higher in W vs M 1.68 (1.08-2.63), but not after 6-months 1.01 (0.73-1.39). The higher
early mortality in W was noted only among ST-elevation (STE) ACS pts: 19.4%W vs
11.5%M; OR 1.96 (1.15-3.37), but not among non-STE ACS pts: 3.9%W vs 3.7%M; OR
0.75 (0.28-1.86).
Conclusion: Elderly W vs M with ACS had similar frequency of STE, complication rates
and received similar medical and revascularization management. The early higher mor-
tality rate in elderly STE-ACS W suggests that an aggressive approach should be
explored in this high risk group.
Age Groups (years) <65
(N=2143)
65–74
(N=1312)
>75
(N=1172)
In-hospital Management (%)
Thrombolytics/primary PCI (eligible patients)* 72.3 53.4 40.1
Aspirin* 95.3 90.3 88.4
Any Heparin* 93.7 89.9 86.6
Glycoprotein IIb/IIIa inhibitor* 9.2 6.0 3.9
Catheterization* 45.8 40.1 28.5
Percutaneous intervention (PCI)* 20.9 14.1 12.0
Coronary artery bypass graft (CABG)** 4.5 3.9 2.7
Medications Utilization and Outcome at 1-year (%)
Aspirin* 87.6 81.3 75.6
Beta-blockers* 69.1 65.3 60.9
Lipid lowering agents* 75.4 72.3 48.8
Death* 3.2 10.1 20.4
Death/MI* 10.0 16.1 26.5
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1070-133 Increased Capillary Fluid Filtration Rate in Elderly 
Subjects With Symptomatic Hypotension During Head-
Up Tilt Table Testing
Scott L. Hummel, Mathew Maurer, Columbia University, New York, NY
Background: Progressive orthostatic hypotension during head up tilt table testing is
common in elderly subjects. The role of venous pooling in the genesis of symptomatic
hypotension is unknown. We compared the degree of venous pooling in the lower limb
during head up tilt in a cohort of healthy elderly persons with and without symptomatic
progressive orthostatic hypotension.
Methods: 33 subjects, age 77±9 years (range 61-96 years), 64% female underwent
head up tilt table testing (TTT) at 60° for 30 minutes or until symptomatic hypotension.
Strain gauge plethysmography of the calf was performed during head up tilt with the
capacitance response (Va) determined from the volume increase at the onset of tilt to the
line defined by the filtration slope (Jv) that represents the rate of fluid filtration during
orthostatic stress.
Results: Six subjects (18%) had symptomatic hypotension (SH) necessitating premature
termination of the TTT after 11±6 minutes most of whom exhibited a progressive form of
orthostatic hypotension. Age, gender and resting blood pressure and heart rate did not
differ between subjects with and without SH. Venous capacitance (Va) did not differ (2.2 ±
0.3 ml/100 ml vs 2.1 ± 0.9 ml/100 ml, p=0.7) but the rate of fluid filtration (Jv) was more
than double in subjects with SH compared to elderly subjects without SH (0.4±0.28 vs
0.16±0.09 ml/100 ml/min, p=0.08).
Conclusions: While venous capacitance is not different in elderly subjects with and with-
out SH during head up TTT, the rate of fluid filtration is higher in subjects with SH. These
data suggest that a more precise understanding of the factors that affect venous pooling
during upright posture may help clarify the pathophysiology of orthostatic tolerance in
elderly subjects.
1070-134 Effect of Successful Percutaneous Coronary 
Intervention on 30-Day Mortality in Elderly Patients With 
Acute Myocardial Infarction
Daisaku Nakatani, Hiroshi Sato, Kunihiro Kinjo, Hiroya Mizuno, Masahiko Shimizu, 
Masatsugu Hori, Osaka University Graduate School of Medicine, Internal Medicine and 
Therapeutics, Suita, Japan
Background: Several randomized and observational studies demonstrated that percuta-
neous coronary intervention (PCI) is alternative reperfusion strategy to thrombolysis in
elderly patients with acute myocardial infarction (AMI). However, there are few evidences
of the effect of successful PCI on mortality in elderly patients with AMI. Methods and
Results: To examine the effect of successful PCI on 30-day mortality in elderly patients,
we studied 2406 patients who were registered in the Osaka Acute Coronary Insufficiency
Study (OACIS) and who were treated with PCI within 24 hours after onset of AMI. These
patients were divided into 3 groups according to age (<65y; n=1200, 65-74y; n=750,
>75y; n=456). We compared risk ratio of 30-day mortality in successful PCI, defined as
achieving final TIMI grade 3 flow, in each age group. In each 3 group, the 30-day mortality
rate was lower in patients with successful PCI than those without successful PCI (<65y;
2.2% vs 4.4%, P=0.08), (65-74y; 4.8% vs 18.4%, P<0.01), and (>75y; 7.5% vs 18.8%,
P<0.01), respectively._After adjustment for clinical variables, the risk reduction for 30-day
mortality in successful PCI group compared with that in unsuccessful PCI group was
greater for patients in the 65-74y group (risk ratio [RR], 0.34: 95% CI; 0.13-0.94, P=0.04)
and in the >75y group (RR; 0.28, 95% CI; 0.10-0.78, P=0.02) than those in the <65y
group (RR; 0.59 95% CI; 0.13-2.82, P=0.51). The incidence of major bleeding was similar
among the 3 groups, even in patients treated with stent implantation. Conclusion: Com-
pared to the younger patients, the beneficial effect of successful reperfusion on 30-day
mortality is greatest in the elderly patients with AMI. Therefore, strategy to achieve TIMI
grade 3 flow is crucial, especially in elderly patients with AMI.
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806-1 Pattern of Cardiac Isoenzyme Elevation in Probable 
Smallpox Associated Myocarditis
Robert E. Eckart, Dimitri C. Cassimatis, John E. Atwood, Suzanne S. Love, Charles L. 
Campbell, Wayne Scott, Renata J. M. Engler, Limone C. Collins, Mark K. Arness, James 
R. Riddle, John D. Grabenstein, for the Dept of Defense Smallpox Vaccination Clinical 
Evaluation Team, Brooke Army Medical Center, Fort Sam Houston, TX, Walter Reed 
Army Medical Center, Washington, DC
Introduction: As of 31 July 2003, a total of 53 military personnel were identified with
confirmed or probable acute myopericarditis following smallpox vaccination. The diagno-
sis was frequently made based on elevation of cardiac isoenzymes and ECG manifesta-
tions of diffuse ST-segment elevation. We sought to determine the range and pattern of
cardiac isoenzyme elevation in the patient presenting with probable smallpox associated
myocarditis.
Methods: The cases were identified either through active or passive surveillance. We
examined cardiac enzymes of patients presenting with probable vaccinia associated
myocarditis.
Results: There were 47 patients (mean age, 27±5 years) who had 397 biochemical
assays [creatine kinase (CK), creatine kinase-MB (CKMB) isoform, and troponin-I] avail-
able for review. The mean troponin-I on presentation was 10.5±23.4 ng/mL, with no sta-
tistically or clinically significant decrease in troponin-I between 6-24 hours (10.5±15.7 ng/
mL) and 24-48 hours (10.1±19.0 ng/mL). There was a clinically significant decrease in
troponin-I after 48 hours (4.9±4.7 ng/mL) and after 96 hours (0.02±0.02 ng/mL). There
was a statistically significant difference in isoenzyme levels at time of presentation com-
pared to samples obtained within 24-48 hours of presentation of both CK (447±345 vs.
188±138 IU/L, p<0.001) and CKMB (22.6±28.9 vs. 11.5±12.4 ng/mL, p=0.047). The
mean peak troponin-I of 14.8±26.5 ng/mL occurred at a median of 6.7 hours from pre-
sentation, and the mean CKMB of 438±339 ng/mL occurred at a median of 5.9 hours
from presentation. When comparing those with (n=15) and without (n=19) ST elevation
on presenting ECG, there was a clinically significant difference in peak troponin-I
(25.6±40.0 vs. 7.3±9.2 ng/mL, p=0.09) and CK (510±380 vs. 315±231 IU/L, p=0.07).
Conclusions: Unlike the characteristic rise and fall of biochemical assays in acute myo-
cardial infarction, patients with probable vaccinia associated myocarditis present with
peak elevation of cardiac enzymes, and may have a sustained elevation of troponin-I for
up to 4 days after presentation. There may be an association between quantitative injury
and ECG findings in acute myopericarditis.
9:30 a.m.
806-2 Is Sporadic Arrhythmogenic Right Ventricular 
Cardiomyopathy an Infectious Disease?
Bernhard Maisch, Sabine Pankuweit, Renu Virmani, Philipps-University, Marburg, 
Germany, Armed Forces Institute, Washington
Background: Genetic predisposition is verified in arrhythmogenic right ventricular cardi-
omyopathy (ARVCM), however, infection and inflammation are discussed as concommit-
tant etiopathogenetic factors particularly in sporadic forms.
Methods: 18 post mortem and 4 right ventricular biopsy specimens from patients with
histologically validated fibrofatty degenerative ARVCM (14 males, 8 female; mean age
31.1±18.2 years; 18 died from sudden death, 4 alive with VT) were examined for infiltrat-
ing lymphocytes by mabs to CD45Ro(actT), CD3(T), CD8(Th), CD20(B), and by PCR to
the RNA of entero-(EV), the DNA of adeno-(AV), cytomegalo(CMV), Ebstein Barr Virus
(EBV), Parvo B19(PB19) or Borreliosis (Borr).
Results: Sparse accumulation (<7 but > 3/mm²) of CD45Ro positive cells was found in 9/
22 patients (40.9%), a substantial act T or T-cell infiltrate (>14/mm² ) in 1/20 patients
(4,7%) only. Mab to a-actinin gave incoherent binding in 7 from 21 pts (33.3%), so dem-
onstrating structural abnormalities. The incidence of virus positive probes were remark-
ably high, when compared to controls (n=50)(% positive):
Conclusions: The data substantiate a possible role of viral infection in the pathogenesis
of sporadic ARVCM.
Women (n=511) Men (n=820) p Value
Age yrs (mean+SD) 79+5 78+6 ns
Diabetes (%) 40 33 0.007
Hypertension (%) 74 58 <0.0001
Hyperlipidemia (%) 48 37 <0.0001
Prior MI (%) 29 39 0.0002
Prior PCI/CABG (%) 18 35 <0.0001
ST Elevation (%) 50 44 ns
Admission Killip Class>II (%) 34 33 ns
Q-wave (%) 47 42 ns
Thrombolysis (%) 32 30 ns
Coronary Angiography (%) 46 50 ns
Primary PCI in STE pts (%) 15 16 ns
Aspirin (%) 89 90 ns
Beta-Blockers (%) 61 61 ns
ACE inhibitors (%) 57 60 ns
Statins (%) 41 36 ns
7-day Mortality (%) 11.6 7.2 0.007
6-month Mortality (%) 21 19.4 ns
Number of detected viruses [% positive]
Virus EV ADV CMV EBV PB19 Borr total
ARVC 4.5 18.2 9.1 4.5 9.1 0 45
Control 0 2 2 0 0 0 8
